Business · 28/08/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Cellular, Tissue, and Gene Therapies Advisory Committee
Summary
The FDA is hosting a public meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee to provide advice on FDA's regulatory issues, and the meeting is open to the public.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →